Cart
sales@molnova.com
BMS-833923
CAS No. 1059734-66-5
BMS-833923( XL-139 )
Catalog No. M17789 CAS No. 1059734-66-5
BMS-833923, an orally bioavailable Smoothened antagonist, inhibits BODIPY cyclopamine binding to SMO in a dose-dependent manner (IC50: 21 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 51 | In Stock |
|
| 5MG | 44 | In Stock |
|
| 10MG | 70 | In Stock |
|
| 25MG | 123 | In Stock |
|
| 50MG | 193 | In Stock |
|
| 100MG | 350 | In Stock |
|
| 200MG | 514 | In Stock |
|
| 500MG | 817 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBMS-833923
-
NoteResearch use only, not for human use.
-
Brief DescriptionBMS-833923, an orally bioavailable Smoothened antagonist, inhibits BODIPY cyclopamine binding to SMO in a dose-dependent manner (IC50: 21 nM).
-
DescriptionBMS-833923, an orally bioavailable Smoothened antagonist, inhibits BODIPY cyclopamine binding to SMO in a dose-dependent manner (IC50: 21 nM).
-
In Vitro——
-
In Vivo——
-
SynonymsXL-139
-
PathwayApoptosis
-
TargetIL Receptor
-
RecptorSmoothened
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1059734-66-5
-
Formula Weight473.57
-
Molecular FormulaC30H27N5O
-
Purity>98% (HPLC)
-
SolubilityDMSO : 50 mg/mL 105.58 mM;
-
SMILESc12c(c(nc(n1)Nc1ccc(cc1)C(=O)Nc1cc(ccc1C)CNC)c1ccccc1)cccc2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
IL-2-IN-1
IL-2-IN-1 is a potent inhibitor of IL-2 (IC50: 1978 nM) and demonstrates anti-proliferative effects.
-
NFAT inhibitor, Cell...
NFAT inhibitor. Inhibits LPS or LPS plus IFN-γ-induced IL-12 p40, IL-12 p70, IL-23 and TNF secretion from bone marrow-derived macrophages (BMDMs). Also attenuates NO production and Nos2 mRNA expression in LPS-stimulated BMDMs. Improves symptoms in a mouse model of colitis. Exhibits immunosuppressive effects; enhances graft survival in mice. Cell permeable.
-
Nothofagin
Nothofagin has antioxidant, and antithrombotic activities, it possesses anti-inflammatory activity by inhibiting hyperpermeability, expression of CAMs, and adhesion and migration of leukocytes, thereby endorsing its usefulness as a therapy for vascular inflammatory diseases.
